U.S. regulators say J&J's single-dose vaccine protects against COVID-19. The report says overall the vaccine is about 66% effective at preventing moderate to severe COVID. This sets the stage for a final decision on FDA emergency use. (Feb. 24)       

Topics:  j&j   fda    feb   covid   prevent   dose vaccine   
BING NEWS:
  • UPDATED: Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
    While the survival advantage swung in Carvykti’s favor after 10 months of the study, J&J noted that the increased death risk was essentially limited to the first three months. During that period ...
    03/15/2024 - 2:58 am | View Link
  • US expert panel recommends authorization of Johnson & Johnson's COVID-19 vaccine
    A US expert panel on Friday, February 26, endorsed Johnson & Johnson’s one-dose COVID-19 vaccine. Also, the FDA is expected to make a final decision soon. This comes after the regulators analysed the ...
    02/26/2021 - 6:35 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News